Shared Resources

Partners in Innovation

Fred Hutchinson Cancer Research Center’s in-house expertise puts world-class technologies at your fingertips. Through Shared Resources, investigators in the Fred Hutch/University of Washington Cancer Consortium and at external academic and industry organizations can access cutting-edge services tailored to their specific research goals, including novel assay development or early access to new technologies.

Shared Resources comprises over a dozen cores that help drive advances by integrating dedicated experts and sophisticated technologies across the entire research pipeline, from basic science to clinical trials. This seamless experience encompasses all phases of technology selection, experimental design, and data generation and analysis.

Resources for Science

Our 14 Shared Resources cores offer investigators dozens of specialized scientific services and access to the latest equipment and tools. The cores’ expert staff assist with experimental design, collaborate on project planning, create customized tests and software, provide data analysis, ensure regulatory compliance, and deliver hundreds of hours of training to researchers each year.

14

Shared Resources Cores
Our Consortium and scientific divisions manage another two dozen cores.

>180

Specialized Staff
Our shared resources are operated by experts in their fields.

>57K

Square Feet
Shared Resources cores are a significant Fred Hutch investment.

How We Advance Science

Fred Hutch Shared Resources cores are powerful assets for science. From genomics to microscopy to proteomics, these resources provide centralized, equitable and efficient access to powerful technologies and expertise in support of scientific discovery.

In addition to our work within our Cancer Consortium, Shared Resources cultivates partnerships with external institutions and clients in academia and industry. We’re proud to offer scientists and biotechnology partners around the country the opportunity to access our scientific services in support of their basic, translational or clinical research.

Areum Yoon works in our Preclinical Modeling Core Lab's program in genetically engineered mouse models.
Areum Yoon works in our Preclinical Modeling Core Lab's program in genetically engineered mouse models. Photo by Robert Hood / Fred Hutch News Service

"Well-run shared resources that meet our investigators’ needs are critical to our continued scientific excellence."

— Steve Stadum, Executive Vice President and COO

Last Modified, October 20, 2020